Dynamic evolution of CIKS (TRAF3IP2/Act1) in metazoans

Developmental and Comparative Immunology

Volumn 35, Issue 11, 2011, Pages

  Wu, Baojun ^a   Jin, Meng ^a   Gong, Jing ^b   Du, Xiumin ^a,c   Bai, Zengliang ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

CIKS; CIKSL; Comparative genomics; Evolution; Metazoan3

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; NUCLEAR FACTOR KAPPA B ACTIVATOR 1; TRAF3 INTERACTING PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; BRANCHIOSTOMA FLORIDAE; CAENORHABDITIS ELEGANS; CIKS GENE; CIKSL GENE; COMPARATIVE STUDY; GENE; GENE DUPLICATION; GENE EXPRESSION; GENOME; INVERTEBRATE; LOTTIA GIGANTEA; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRONGYLOCENTROTUS; SYNTENY;

BACTERIA (MICROORGANISMS); BRANCHIOSTOMA FLORIDAE; BRANCHIOSTOMA LANCEOLATUM; CEPHALOCHORDATA; ECHINOIDEA; INVERTEBRATA; LOTTIA; LOTTIA GIGANTEA; MAMMALIA; METAZOA; STRONGYLOCENTROTUS PURPURATUS; VERTEBRATA;

EID: 80053337975     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2011.03.027     Document Type: Article

References (32)

1. Agarwal S., Misra R., Aggarwal A. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J. Rheumatol. 2008, 35:515-519.
2. Bridgham J.T., Brown J.E., Rodriguez-Mari A., Catchen J.M., Thornton J.W. Evolution of a new function by degenerative mutation in cephalochordate steroid receptors. PLoS Genet. 2008, 4:e1000191.
3. Coope H.J., Atkinson P.G., Huhse B., Belich M., Janzen J., Holman M.J., Klaus G.G., Johnston L.H., Ley S.C. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 2002, 21:5375-5385.
4. Davies C.C., Mak T.W., Young L.S., Eliopoulos A.G. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Mol. Cell Biol. 2005, 25:9806-9819.
5. Hellsten U., Harland R.M., Gilchrist M.J., Hendrix D., Jurka J., Kapitonov V., Ovcharenko I., Putnam N.H., Shu S., Taher L., Blitz I.L., Blumberg B., Dichmann D.S., Dubchak I., Amaya E., Detter J.C., Fletcher R., Gerhard D.S., Goodstein D., Graves T., Grigoriev I.V., Grimwood J., Kawashima T., Lindquist E., Lucas S.M., Mead P.E., Mitros T., Ogino H., Ohta Y., Poliakov A.V., Pollet N., Robert J., Salamov A., Sater A.K., Schmutz J., Terry A., Vize P.D., Warren W.C., Wells D., Wills A., Wilson R.K., Zimmerman L.B., Zorn A.M., Grainger R., Grammer T., Khokha M.K., Richardson P.M., Rokhsar D.S. The genome of the Western clawed frog Xenopus tropicalis. Science 2010, 328:633-636.
6. Hibino T., Loza-Coll M., Messier C., Majeske A.J., Cohen A.H., Terwilliger D.P., Buckley K.M., Brockton V., Nair S.V., Berney K., Fugmann S.D., Anderson M.K., Pancer Z., Cameron R.A., Smith L.C., Rast J.P. The immune gene repertoire encoded in the purple sea urchin genome. Dev. Biol. 2006, 300:349-365.
7. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
8. Kanamori M., Kai C., Hayashizaki Y., Suzuki H. NF-kappaB activator Act1 associates with IL-1/Toll pathway adaptor molecule TRAF6. FEBS Lett. 2002, 532:241-246.
9. Kasahara M. The 2R hypothesis: an update. Curr. Opin. Immunol. 2007, 19:547-552.
10. Kayagaki N., Yan M., Seshasayee D., Wang H., Lee W., French D.M., Grewal I.S., Cochran A.G., Gordon N.C., Yin J., Starovasnik M.A., Dixit V.M. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 2002, 17:515-524.
11. Leonardi A., Chariot A., Claudio E., Cunningham K., Siebenlist U. CIKS, a connection to Ikappa B kinase and stress-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10494-10499.
12. Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 2008, 41:105-113.
13. Li X., Commane M., Nie H., Hua X., Chatterjee-Kishore M., Wald D., Haag M., Stark G.R. Act1, an NF-kappa B-activating protein. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10489-10493.
14. Lubberts E., Schwarzenberger P., Huang W., Schurr J.R., Peschon J.J., van den Berg W.B., Kolls J.K. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J. Immunol. 2005, 175:3360-3368.
15. Lupas A. Prediction and analysis of coiled-coil structures. Methods Enzymol. 1996, 266:513-525.
16. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 1999, 190:1697-1710.
17. Mehling A., Loser K., Varga G., Metze D., Luger T.A., Schwarz T., Grabbe S., Beissert S. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 2001, 194:615-628.
18. Munroe M.E., Bishop G.A. Role of tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) in distinct and overlapping CD40 and TNF receptor 2/CD120b-mediated B lymphocyte activation. J. Biol. Chem. 2004, 279:53222-53231.
19. Novatchkova M., Leibbrandt A., Werzowa J., Neubuser A., Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 2003, 28:226-229.
20. Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010, 129:311-321.
21. Pang Q., Zhang S., Liu X., Wu D. Humoral immune responses of amphioxus Branchiostoma belcheri to challenge with Escherichia coli. Fish Shellfish Immunol. 2006, 21:139-145.
22. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., Xiao J., Lu Y., Giltiay N., Liu J., Kordula T., Zhang Q.W., Vallance B., Swaidani S., Aronica M., Tuohy V.K., Hamilton T., Li X. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 2007, 8:247-256.
23. Qian Y., Qin J., Cui G., Naramura M., Snow E.C., Ware C.F., Fairchild R.L., Omori S.A., Rickert R.C., Scott M., Kotzin B.L., Li X. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004, 21:575-587.
24. Qian Y., Zhao Z., Jiang Z., Li X. Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:9386-9391.
25. Robert J., Cohen N. The genus Xenopus as a multispecies model for evolutionary and comparative immunobiology of the 21st century. Dev. Comp. Immunol. 2011, 014. 10.1016/j.dci.2011.01.
26. Schwandner R., Yamaguchi K., Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 2000, 191:1233-1240.
27. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
28. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
29. Wang T., Martin S.A., Secombes C.J. Two interleukin-17C-like genes exist in rainbow trout Oncorhynchus mykiss that are differentially expressed and modulated. Dev. Comp. Immunol. 2010, 34:491-500.
30. Yao Z., Spriggs M.K., Derry J.M., Strockbine L., Park L.S., VandenBos T., Zappone J.D., Painter S.L., Armitage R.J. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 1997, 9:794-800.
31. Zhang Z., Zheng M., Bindas J., Schwarzenberger P., Kolls J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel. Dis. 2006, 12:382-388.
32. Zhao Z., Qian Y., Wald D., Xia Y.F., Geng J.G., Li X. IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J. Immunol. 2003, 170:5674-5680.